Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial
Abstract Background We aimed to evaluate the effects of short-term therapy with dapagliflozin on serum uric acid (SUA) and urinary uric acid (UUA) levels in patients with type 2 diabetes. Methods In this prospective pilot trial, 8 patients with type 2 diabetes mellitus were assigned to the treatment...
Main Authors: | Tao Yuan, Shixuan Liu, Yingyue Dong, Yong Fu, Yan Tang, Weigang Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13098-020-00600-9 |
Similar Items
-
Medium- and Long-Term Effects of Dapagliflozin on Serum Uric Acid Level in Patients with Type 2 Diabetes: A Real-World Study
by: Shihan Wang, et al.
Published: (2022-12-01) -
Effects of dapagliflozin on serum uric acid levels in hospitalized type 2 diabetic patients with inadequate glycemic control: a randomized controlled trial
by: Hao Z, et al.
Published: (2018-12-01) -
Urinary excretion of uric acid is negatively associated with albuminuria in patients with chronic kidney disease: a cross-sectional study
by: Fengqin Li, et al.
Published: (2018-04-01) -
The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus
by: Paula Sánchez-Briales, et al.
Published: (2024-02-01) -
Changes of serum uric acid level during acute gout flare and related factors
by: Jie Zhang, et al.
Published: (2023-02-01)